These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30391064)

  • 1. Factors associated with objectively measured exercise participation after hospitalization for acute coronary syndrome.
    Goodwin AM; Duran AT; Kronish IM; Moise N; Sanchez GJ; Garber CE; Schwartz JE; Diaz KM
    Int J Cardiol; 2019 Jan; 275():1-5. PubMed ID: 30391064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International data on supportive therapies at 1 year in acute coronary syndrome patients undergoing PCI: results from the APTOR study.
    Bakhai A; Ferrieres J; Iñiguez A; Schmitt C; Sartral M; Belger M; Zeymer U
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):518-25. PubMed ID: 21450649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of Physical Activity and In-Hospital Course of Patients with Acute Coronary Syndrome.
    Jorge Jde G; Santos MA; Barreto Filho JA; Oliveira JL; de Melo EV; de Oliveira NA; Faro GB; Sousa AC
    Arq Bras Cardiol; 2016 Jan; 106(1):33-40. PubMed ID: 26690692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.
    Gunnell AS; Hung J; Knuiman MW; Nedkoff L; Gillies M; Geelhoed E; Hobbs MS; Katzenellenbogen JM; Rankin JM; Ortiz M; Briffa TG; Sanfilippo FM
    Cardiovasc Ther; 2016 Dec; 34(6):423-430. PubMed ID: 27489053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes [SMART-REHAB Trial]: a randomized controlled trial protocol.
    Yudi MB; Clark DJ; Tsang D; Jelinek M; Kalten K; Joshi S; Phan K; Nasis A; Amerena J; Arunothayaraj S; Reid C; Farouque O
    BMC Cardiovasc Disord; 2016 Sep; 16(1):170. PubMed ID: 27596569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of an internet-based computer-tailored expert system for physical activity in patients with heart disease.
    Reid RD; Morrin LI; Beaton LJ; Papadakis S; Kocourek J; McDonnell L; Slovinec D'Angelo ME; Tulloch H; Suskin N; Unsworth K; Blanchard C; Pipe AL
    Eur J Prev Cardiol; 2012 Dec; 19(6):1357-64. PubMed ID: 21903744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of patients living without a partner or spouse to being physically active after acute coronary syndromes (from the PULSE accelerometry substudy).
    Green P; Newman JD; Shaffer JA; Davidson KW; Maurer MS; Schwartz JE
    Am J Cardiol; 2013 May; 111(9):1264-9. PubMed ID: 23411104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based prescribing of drugs for secondary prevention of acute coronary syndrome in Aboriginal and non-Aboriginal patients admitted to Western Australian hospitals.
    Gausia K; Katzenellenbogen JM; Sanfilippo FM; Knuiman MW; Thompson PL; Hobbs MS; Thompson SC
    Intern Med J; 2014 Apr; 44(4):353-61. PubMed ID: 24528930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome.
    Wang CY; Lin ZF; Lee CM; Tsai YW; Huang TY; Shen LJ; Hsiao FY
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):229-238. PubMed ID: 28067454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor.
    Molife C; Frech-Tamas F; DeKoven M; Effron MB; Karkare S; Zhu Y; Larmore C; Lu J; McCollam P; Marrett E; Vetrovec GW
    J Med Econ; 2015; 18(11):898-908. PubMed ID: 26086414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study.
    Brieger D; Chow C; Gullick J; Hyun K; D'Souza M; Briffa T;
    Intern Med J; 2018 May; 48(5):541-549. PubMed ID: 29345403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
    Ho PM; Maddox TM; Wang L; Fihn SD; Jesse RL; Peterson ED; Rumsfeld JS
    JAMA; 2009 Mar; 301(9):937-44. PubMed ID: 19258584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pharmacist Intervention to Increase Compliance With Guideline-Directed Statin Therapy During an Acute Coronary Syndrome Hospitalization.
    Tunney RK; Johnson DC; Wang L; Cox ZL
    Ann Pharmacother; 2017 May; 51(5):394-400. PubMed ID: 28058865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score.
    Raposeiras-Roubín S; Faxén J; Íñiguez-Romo A; Henriques JPS; D'Ascenzo F; Saucedo J; Szummer K; Jernberg T; James SK; Juanatey JRG; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Moretti C; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; Caneiro-Queija B; Cobas-Paz R; Acuña JMG; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Giordana F; Gaita F; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Kedev S; Rivera-Asenjo D; Abu-Assi E
    Int J Cardiol; 2018 Mar; 254():10-15. PubMed ID: 29407077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Physical Activity and Metabolic Syndrome: Comparison Between Self-Report and Accelerometry.
    Tucker JM; Welk GJ; Beyler NK; Kim Y
    Am J Health Promot; 2016; 30(3):155-62. PubMed ID: 25806568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Changes in Objectively Measured Moderate to Vigorous Physical Activity in Patients After Percutaneous Coronary Intervention: A Prospective Cohort Study.
    Funaki K; Adachi T; Kameshima M; Fujiyama H; Iritani N; Tanaka C; Sakui D; Hara Y; Sugiura H; Yamada S
    J Phys Act Health; 2023 Apr; 20(4):279-291. PubMed ID: 36812917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objectively Measured Adherence to Physical Activity Guidelines After Acute Coronary Syndrome.
    Kronish IM; Diaz KM; Goldsmith J; Moise N; Schwartz JE
    J Am Coll Cardiol; 2017 Mar; 69(9):1205-1207. PubMed ID: 28254185
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome.
    Bezin J; Groenwold RH; Ali MS; Lassalle R; Robinson P; de Boer A; Moore N; Klungel OH; Pariente A
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):285-293. PubMed ID: 28124399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.